Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cellular and Molecular Life Sciences | journal | 3.259 Q1 | 261 | 305 | 919 | 38436 | 5674 | 909 | 6.22 | 126.02 | 42.51 | |
2 | Frontiers in Pharmacology | journal | 1.729 Q1 | 154 | 515 | 725 | 33384 | 3101 | 671 | 4.37 | 64.82 | 43.94 | |
3 | Pharmaceuticals | journal | 1.553 Q1 | 87 | 77 | 172 | 6189 | 897 | 165 | 4.62 | 80.38 | 48.70 | |
4 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | 52.08 | |
5 | Inflammation Research | journal | 1.025 Q2 | 107 | 97 | 327 | 4549 | 946 | 324 | 2.82 | 46.90 | 42.24 | |
6 | Pharmaceutics | journal | 0.984 Q1 | 106 | 34 | 109 | 2038 | 442 | 107 | 3.65 | 59.94 | 37.01 | |
7 | Toxins | journal | 0.984 Q2 | 116 | 371 | 708 | 22872 | 2562 | 693 | 3.16 | 61.65 | 42.24 | |
8 | Skin Pharmacology and Physiology | journal | 0.945 Q2 | 86 | 33 | 114 | 1379 | 328 | 111 | 3.10 | 41.79 | 53.15 | |
9 | Inflammopharmacology | journal | 0.941 Q2 | 68 | 43 | 109 | 1799 | 335 | 104 | 2.96 | 41.84 | 31.82 | |
10 | Progress in Drug Research | book series | 0.905 Q1 | 46 | 33 | 31 | 189 | 117 | 26 | 3.77 | 5.73 | 0.00 | |
11 | Marine Drugs | journal | 0.883 Q2 | 159 | 234 | 1028 | 15798 | 4269 | 1026 | 4.08 | 67.51 | 42.17 | |
12 | Molecules | journal | 0.825 Q1 | 227 | 1759 | 3657 | 90664 | 12187 | 3643 | 3.24 | 51.54 | 40.16 | |
13 | AAPS PharmSciTech | journal | 0.766 Q1 | 116 | 147 | 427 | 6034 | 1102 | 424 | 2.43 | 41.05 | 34.93 | |
14 | Antibiotics | journal | 0.714 Q1 | 77 | 37 | 111 | 2457 | 234 | 108 | 2.08 | 66.41 | 41.04 | |
15 | Current Pharmacology Reports | journal | 0.702 Q2 | 35 | 34 | 42 | 3104 | 102 | 42 | 2.43 | 91.29 | 33.68 | |
16 | Pharmacology | journal | 0.569 Q3 | 67 | 76 | 253 | 2417 | 424 | 251 | 1.62 | 31.80 | 38.80 | |
17 | Chemotherapy | journal | 0.536 Q2 | 61 | 46 | 158 | 1551 | 272 | 156 | 1.73 | 33.72 | 42.09 | |
18 | Modern Trends in Pharmacopsychiatry | journal | 0.524 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
19 | Molecular Diversity | journal | 0.463 Q2 | 63 | 72 | 210 | 3693 | 417 | 210 | 1.81 | 51.29 | 35.23 | |
20 | Developments in Biologicals | journal | 0.445 Q3 | 41 | 0 | 22 | 0 | 30 | 21 | 0.00 | 0.00 | 0.00 | |
21 | Antibodies | journal | 0.341 Q3 | 42 | 21 | 71 | 2063 | 108 | 70 | 1.00 | 98.24 | 40.74 | |
22 | Scientia Pharmaceutica | journal | 0.323 Q2 | 54 | 55 | 184 | 1551 | 246 | 182 | 1.03 | 28.20 | 41.62 | |
23 | Botulinum Journal | journal | 0.230 Q3 | 6 | 6 | 4 | 302 | 2 | 3 | 0.00 | 50.33 | 40.00 | |
24 | Pharmacoeconomics - Spanish Research Articles | journal | 0.104 Q4 | 6 | 16 | 46 | 411 | 5 | 46 | 0.06 | 25.69 | 48.57 | |
25 | Cosmetics | journal | 44 | 41 | 53 | 2373 | 55 | 50 | 1.04 | 57.88 | 60.18 | ||
26 | EJNMMI Radiopharmacy and Chemistry | journal | 28 | 13 | 0 | 386 | 0 | 0 | 0.00 | 29.69 | 22.58 | ||
27 | Journal of Cardiovascular Development and Disease | journal | 32 | 33 | 37 | 3037 | 48 | 35 | 1.30 | 92.03 | 50.00 | ||
28 | Journal of Xenobiotics | journal | 11 | 2 | 6 | 47 | 3 | 2 | 0.50 | 23.50 | 50.00 | ||
29 | Toxics | journal | 51 | 28 | 60 | 1908 | 111 | 58 | 1.94 | 68.14 | 50.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®